Content area

|
|

Controlled attenuation parameter er en ny metode til screening for ikkealkoholisk fedtleversygdom

Forfattere
Jacob Søholm1, Maja Sofie Thiele2 & Peer Brehm Christensen1 1) Infektionsmedicinsk Afdeling Q, Odense Universitetshospital 2) Afdeling for Medicinske Mavetarmsygdomme, Odense Universitetshospital Ugeskr Læger 2018;180:V05170414
Reference: 
Ugeskr Læger 2018;180:V05170414
Sidetal: 
2-5
Controlled attenuation parameter is a novel technique in screening for non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease afflicts 30% of the population and is tightly linked to the metabolic syndrome and development of cardiovascular disease and chronic liver disease. Regular ultrasound is currently used in liver steatosis diagnosing, but it is operator-dependent, fails to detect lower grades of steatosis, and is unable to graduate the degree of steatosis. Controlled attenuation parameter is a novel, ultrasound-based technique to accurately detect and grade steatosis. Further studies are needed to establish cut-offs, before it can be implemented in clinical practice.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Morten Krause Nielsen | 25/05
1 Kommentar
af Frank Krarup Andersen | 25/05
2 kommentarer
af Camilla Slot Mehlum | 25/05
1 Kommentar
af Frederik Liljefred | 23/05
1 Kommentar
af Eva Godzik Sadola | 23/05
1 Kommentar
af John Henrik Jurlander | 22/05
1 Kommentar
af Nicolas Storm | 19/05
3 kommentarer
af Sten Arne Oyre | 18/05
2 kommentarer
af Pedram Kazemi-Esfarjani | 18/05
2 kommentarer